Details for New Drug Application (NDA): 018899
✉ Email this page to a colleague
NDA 018899 describes ISOLYTE E IN PLASTIC CONTAINER, which is a drug marketed by B Braun and is included in two NDAs. Additional details are available on the ISOLYTE E IN PLASTIC CONTAINER profile page.
The generic ingredient in ISOLYTE E IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate. There are two hundred and eighty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate profile page.
The generic ingredient in ISOLYTE E IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate. There are two hundred and eighty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate profile page.
Summary for 018899
| Tradename: | ISOLYTE E IN PLASTIC CONTAINER |
| Applicant: | B Braun |
| Ingredient: | calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 35MG/100ML;30MG/100ML;74MG/100ML;640MG/100ML;500MG/100ML;74MG/100ML | ||||
| Approval Date: | Oct 31, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
